StockData
Merck & Co., Inc. logo

Merck & Co., Inc.

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30250% above fair value
$148.36−1.16 (-0.78%)

Close on Nov 2, 2026Market cap $366.03BP/E 118.7Yield 2.21%

Merck Inventories — Raw Materials and Work in Process by Year

Inventories — Raw Materials and Work in Process ($M) ($M)

Merck Inventories — Raw Materials and Work in Process: $10,645M in FY2025, up 20.5% from a year earlier.

Latest, FY2025
10,645
Period ended Dec 31, 2025
Change on a year earlier
+20.5%
8,831 in FY2024
History
4 years
Since FY2022
Sources
4
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-Q (filed 2026-08-07) ↗

Reported in Form 10-Q / 10-K Note 7 Inventories.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedInventories — Raw Materials and Work in Process ($M) ($M)Year on yearSource
FY2025Dec 31, 202510,645+20.5%Form 10-Q (filed 2026-08-07) ↗
FY2024Dec 31, 20248,831+9.9%Form 10-K (filed 2026-02-24) ↗
FY2023Dec 31, 20238,037+13.8%Form 10-K (filed 2025-02-25) ↗
FY2022Dec 31, 20227,063–Form 10-K (filed 2024-02-26) ↗

Cite this data

StockData. (2026). Merck Inventories — Raw Materials and Work in Process ($M), annual FY2022–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/inv-stage-wip-raw

See every metric in the Merck KPI table. Data updated Oct 26, 2026.